These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21275944)

  • 21. Use of botulinim toxin-A for the treatment of overactive bladder symptoms in patients with Parkinsons's disease.
    Kulaksizoglu H; Parman Y
    Parkinsonism Relat Disord; 2010 Sep; 16(8):531-4. PubMed ID: 20637678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of botulinum toxin in the pelvic floor for women with chronic pelvic pain-a new answer to old problems?
    Abbott J
    J Minim Invasive Gynecol; 2009; 16(2):130-5. PubMed ID: 19167273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generalized botulism: diagnostic problems in a patient treated with botulinum toxin type A.
    Fota-Markowska H; Mitosek-Szewczyk K; Hasiec T
    Acta Ophthalmol Scand; 2007 Mar; 85(2):231-2. PubMed ID: 17305749
    [No Abstract]   [Full Text] [Related]  

  • 24. Relief of periorbital pain after acute angle closure glaucoma attack by botulinum toxin type A.
    Chien KH; Lu DW; Chen YH; Cheng JH; Chen JT
    J Glaucoma; 2010; 19(8):546-50. PubMed ID: 20164800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation and treatment of synkinesis with botulinum toxin following facial nerve palsy.
    Toffola ED; Furini F; Redaelli C; Prestifilippo E; Bejor M
    Disabil Rehabil; 2010; 32(17):1414-8. PubMed ID: 20156046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum Toxin A in bruxers. One year experience.
    Redaelli A
    Saudi Med J; 2011 Feb; 32(2):156-8. PubMed ID: 21301762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botox for chronic migraine.
    Drug Ther Bull; 2011 Feb; 49(2):22-4; quiz iii-iv. PubMed ID: 21304165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment with botulinum toxin in children with chronic anal fissure.
    Husberg B; Malmborg P; Strigård K
    Eur J Pediatr Surg; 2009 Oct; 19(5):290-2. PubMed ID: 19746337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy and safety of botulinum toxin in the treatment of sialorrhea in children with neurological disorders].
    García Ron A; Miranda MC; Garriga Braun C; Jensen Verón J; Torrens Martinez J; Diez Hanbino MP
    An Pediatr (Barc); 2012 Oct; 77(4):289-91. PubMed ID: 22652186
    [No Abstract]   [Full Text] [Related]  

  • 30. Study of botulinum toxin A in neurogenic bladder due to spina bifida in children.
    Deshpande AV; Sampang R; Smith GH
    ANZ J Surg; 2010 Apr; 80(4):250-3. PubMed ID: 20575951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experience with botulinum toxin type A in medically intractable pediatric chronic daily headache.
    Ahmed K; Oas KH; Mack KJ; Garza I
    Pediatr Neurol; 2010 Nov; 43(5):316-9. PubMed ID: 20933173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of botulinum toxin A for treatment of myofascial pain and dysfunction.
    Fallah HM; Currimbhoy S
    J Oral Maxillofac Surg; 2012 May; 70(5):1243-5. PubMed ID: 22538024
    [No Abstract]   [Full Text] [Related]  

  • 33. [Facial palsy sequel and botulinum toxin].
    Benichou L; Labbe D; Le Louarn C; Guerreschi P
    Ann Chir Plast Esthet; 2015 Oct; 60(5):377-92. PubMed ID: 26432177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Painful leg moving toes treated with botulinum toxin type A: a video report.
    Schoffer K
    Mov Disord; 2010 Apr; 25(6):784-5. PubMed ID: 20310048
    [No Abstract]   [Full Text] [Related]  

  • 35. Botulinum toxin in facial rejuvenation: an update.
    Carruthers J; Carruthers A
    Dermatol Clin; 2009 Oct; 27(4):417-25, v. PubMed ID: 19850191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Botulinum toxin type A in the treatment of Raynaud's phenomenon.
    Neumeister MW
    J Hand Surg Am; 2010 Dec; 35(12):2085-92. PubMed ID: 21134617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inverse psoriasis and hyperhidrosis of the axillae responding to botulinum toxin type A.
    Saber M; Brassard D; Benohanian A
    Arch Dermatol; 2011 May; 147(5):629-30. PubMed ID: 21576592
    [No Abstract]   [Full Text] [Related]  

  • 38. Botulinum toxin to minimize facial scarring.
    Jablonka EM; Sherris DA; Gassner HG
    Facial Plast Surg; 2012 Oct; 28(5):525-35. PubMed ID: 23027220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxin type A for the treatment of gastroparesis in Parkinson's disease patients.
    Gil RA; Hwynn N; Fabian T; Joseph S; Fernandez HH
    Parkinsonism Relat Disord; 2011 May; 17(4):285-7. PubMed ID: 21296606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum toxin A for the management of vulvodynia.
    Yoon H; Chung WS; Shim BS
    Int J Impot Res; 2007; 19(1):84-7. PubMed ID: 16728964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.